-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Neumora Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2024 to Q3 2024.
- Neumora Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $53K.
Income Tax Expense (Benefit), Quarterly (USD)